RAD50 and ovarian carcinoma: Although Rad50‐CARD9 interaction activates NF‐κB pathway that has been reported in dendritic cells,27 we demonstrated that Rad50‐CARD9 interaction activates NF‐κB pathway in ovarian cancer cells.